IP Library Granted Patent US 8,425,944
Granted Patent B2
US 8,425,944 · App. 13/184,007 · Granted Apr 23, 2013

Flavored colonic cleansing system

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,425,944
App. No.
13/184,007
Granted
Apr 23, 2013
Kind
B2
Abstract

A kit for colonic cleansing includes a phosphate salt laxative, a flavorant, and an oral rehydration mixture. The flavorant includes aspartame and a citrate, and the oral rehydration mixture includes sodium and a glucose containing saccharide. The kit may be used for a colonic cleansing procedure by combining the phosphate salt laxative and the flavorant to provide a flavored laxative liquid, orally administering to a subject the flavored laxative liquid, and orally administering to the subject an oral rehydration liquid.

Claims (30)

1. A kit for colonic cleansing, comprising:

a phosphate salt laxative, comprising from 0.4 to 1 gram/mL of monobasic sodium phosphate and from 0.13 to 0.25 gram/mL of dibasic sodium phosphate;

a flavorant, comprising aspartame, maltodextrin, acesulfame potassium and a citrate, wherein about 45 mL of the phosphate salt laxative is present for each 2-6 grams of the flavorant, and

an oral rehydration mixture, comprising sodium, and a glucose containing saccharide.

2. The kit of claim 1 , where the phosphate salt laxative comprises 0.48 gram/mL of monobasic sodium phosphate and 0.18 gram/mL of dibasic sodium phosphate.

3. The kit of claim 1 , where the phosphate salt laxative is present as a solid.

4. The kit of claim 1 , where the phosphate salt laxative is present as an aqueous liquid in at least one bottle.

5. The kit of claim 4 , where the phosphate salt laxative is present as an aqueous liquid in at least two bottles, each bottle comprising from 10 to 75 mL of the liquid.

6. The kit of claim 4 , where the phosphate salt laxative is present as an aqueous liquid in at least six bottles, each bottle comprising from 10 to 75 mL of the liquid.

7. The kit of claim 1 , where the flavorant further comprises a flavoring selected from the group consisting of natural fruit flavors, artificial fruit flavors, and combinations thereof.

8. The kit of claim 1 , where the citrate comprises citric acid and potassium citrate; and the flavorant further comprises natural flavor, lemon juice solids, and artificial color.

9. The kit of claim 1 , where the flavorant further comprises ascorbic acid or a salt thereof.

10. The kit of claim 1 , where the flavorant is present as an aqueous liquid.

11. The kit of claim 1 , where the flavorant is present as a solid.

12. The kit of claim 11 , where the flavorant is present as a powder in at least one packet.

13. The kit of claim 12 , where the flavorant is present as a powder in at least two packets, each packet comprising from 1 to 10 grams of the powder.

14. The kit of claim 1 , where the oral rehydration mixture comprises a ratio of glucose containing saccharide to sodium of 0.1 to 15 g:0.1 to 200 mmol.

15. The kit of claim 1 , where the oral rehydration mixture comprises a ratio of glucose containing saccharide to sodium of 1 to 10 g:2 to 100 mmol.

16. A method for colonic cleansing using the kit of claim 1 , comprising:

combining the phosphate salt laxative and the flavorant to provide a flavored laxative liquid;

orally administering to a subject the flavored laxative liquid; and

orally administering to the subject an oral rehydration liquid,

the oral rehydration liquid comprising sodium and a glucose containing saccharide.

17. A kit for colonic cleansing, comprising:

at least two bottles, each comprising about 45 mL of a phosphate salt laxative, the phosphate salt laxative comprising

water,

from 0.4 to 1 gram/mL of monobasic sodium phosphate, and

from 0.13 to 0.25 gram/mL of dibasic sodium phosphate

at least two packets, each comprising from 2-6 grams of a powdered flavorant, the flavorant comprising

aspartame, maltodextrin, acesulfame potassium and a citrate, wherein about 45 mL of the phosphate salt laxative is present for each 2-6 grams of the flavorant, and at least one packet comprising from 200 to 400 grams of a powdered oral rehydration mixture, the oral rehydration mixture comprising sodium, and a glucose containing saccharide.

Assignments (7)
RELEASE OF TERM SECURITY INTERESTS Recorded Mar 18, 2025
From: BARCLAYS BANK PLC
To: BLACKSMITH BRANDS, INC.; C. B. FLEET COMPANY, INCORPORATED; DENTEK ORAL CARE, INC.; MEDTECH PRODUCTS INC.
Reel/Frame 070542/0447 →
ABL SECURITY AGREEMENT Recorded Jan 31, 2017
From: C.B. FLEET COMPANY INCORPORATED
To: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 041567/0099 →
TERM LOAN SECURITY AGREEMENT Recorded Jan 30, 2017
From: C.B. FLEET COMPANY INCORPORATED
To: BARCLAYS BANK PLC, AS ADMINISTRATIVE AGENT
Reel/Frame 041554/0309 →
RELEASE OF SECURITY INTEREST Recorded Jan 27, 2017
From: GOLUB CAPITAL MARKETS LLC (F/K/A GCI CAPITAL MARKETS LLC)
To: C. B. FLEET COMPANY, INC.; C.B. FLEET INVESTMENT CORPORATION
Reel/Frame 041102/0595 →
SECURITY INTEREST Recorded Oct 24, 2014
From: C. B. FLEET COMPANY, INCORPORATED; C.B. FLEET INVESTMENT CORPORATION
To: GCI CAPITAL MARKETS LLC, AS AGENT
Reel/Frame 034028/0363 →
RELEASE OF SECURITY INTEREST Recorded Oct 24, 2014
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
To: C. B. FLEET COMPANY, INCORPORATED
Reel/Frame 034032/0851 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Mar 15, 2012
From: C. B. FLEET COMPANY, INCORPORATED
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 027873/0492 →